Ventyx Biosciences Debt to Equity

Ventyx Biosciences (VTYX) currently reports a debt-to-equity ratio of 0.05. That is below the sector sector average of 0.2. Use the charts on this page to explore Ventyx Biosciences's debt-to-equity ratio history and peer comparisons.

Ventyx Biosciences's debt-to-equity ratio of 0.05 is lower than the its sector sector average of 0.2. That is roughly 73.8% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

The debt-to-equity ratio is a valuation multiple that relates Ventyx Biosciences's market price to a fundamental measure such as earnings, sales, or book value. At 0.05, VTYX can look expensive or cheap only in context — versus its own history, growth rate, and sector peers. Higher multiples often price in stronger expected growth; lower ones can signal value or concern.

Start with the current debt-to-equity ratio of 0.05, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is 0.2. From there, open related valuation or income-statement pages for Ventyx Biosciences, and consider following VTYX for alerts when major investors trade the stock.